[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.54.109. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correction
March 2005

Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease: A 4-Year Randomized Controlled Trial—Correction

Arch Neurol. 2005;62(3):430. doi:10.1001/archneur.62.3.430

Error in Figure. In Figure 3 of the article titled “Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease: A 4-Year Randomized Controlled Trial,” published in the July issue of the ARCHIVES (2004;61:1044-1053), the lines indicating mean change in Unified Parkinson’s Disease Rating Scale activities of daily living scores during pramipexole and levodopa treatments should be reversed. The top line should indicate pramipexole, and the bottom line should indicate levodopa.

First Page Preview View Large
First page PDF preview
First page PDF preview
×